Navigation Links
Aderans Research BIO International Press Release
Date:5/31/2009

ARI a Key Presence at Recent BIO International Convention

Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companies from 58 countries around the globe at the world's largest annual event for the biotechnology industry, held May 18-21 at the Georgia World Congress Center.

Co-located in Atlanta and Philadelphia, ARI is actively engaged in the study of state-of-the-art cell-based hair regeneration for men and women. The company recently launched Phase 2 of its clinical study to assess the impact of its regenerative cell treatment on pattern hair loss, also known as androgenetic alopecia. Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.

"Our research is focused on generating a tissue engineering solution to the regeneration of hair," said Kurt Stenn, MD, Vice President and Chief Scientific Officer at ARI. "We're using the hair cells from hair follicles and researching methods to promote their growth in controlled laboratory environments. If successful, we'll then be able to recombine the cells and restore them to the scalp, where they would ultimately elicit hair growth."

A dynamic field on the cutting-edge of the hair restoration industry, cell treatment represents a major advance on traditional hair transplant procedures, promising to overcome a key limitation of conventional transplantation: a finite hair supply for any one person. Through leading edge cell engineering, Aderans Research is pioneering efforts to multiply existing hair cells capable of eliciting hair growth, providing patients with a comprehensive solution to hair loss regardless of the quantity of their existing hair.

About the BIO International Convention:
The BIO International Convention is the largest global event for the biotechnology industry, offering key networking and partnering opportunities, and providing insight on major trends affecting the industry. The convention is produced by BIO, the world's largest biotechnology organization, representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad. BIO works to create a favorable policy environment for biotechnological innovation. Its members are involved in marketing, research and development across the healthcare, agriculture, industrial and environmental biotechnology fields.

Learn more at: http://convention.bio.org/

About Aderans Research:
Aderans Research is dedicated to solving the pervasive problem of hair loss and becoming the world leader in the research and development of safe, effective cell engineered products for hair regeneration.

With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI's study outcomes will be released as studies conclude. To see ARI's latest clinical updates, please visit http://aderansresearch.com/ari_clinicalupdates.html

Additional information on ARI can be found at www.aderansresearch.com.

Contact:
Vern Liebmann
Tel: 678.213.1913

###

Read the full story at http://www.prweb.com/releases/hair/regeneration/prweb2478234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aderans Research Launches Second Phase of Hair Loss Study
2. Pitt melanoma researchers present novel findings at ASCO
3. Indiana U. research at the American College of Sports Medicine conference
4. UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimers research
5. Researchers develop light-treatment device to improve sleep quality in the elderly
6. Cancer research partnership between UCSF, MMRF to drive drug development
7. AGA Institute presents cutting-edge research during DDW
8. MU researchers offer insights for advancing health communication through digital media
9. Raymond Tye Named Trustee at Schepens Eye Research Institute
10. 5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
11. LSUHSC dental researcher funded to develop better dental materials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aderans Research BIO International Press Release
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... disease media outlet with a clinician-based audience, will be participating in Rare Disease ... 2017, in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter ...
(Date:2/23/2017)... ... ... Hamlin Dental Group and Dr. Hamid Reza, dentist in North Hollywood ... of February, patients who visit Hamlin Dental Group will receive a ticket for a ... the Cheesecake Factory. , Tickets are available for routine dental visits and other ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... will host a diverse symposium on “Doping in Sport: How the ... Sheppard Mullin Richter & Hampton LLP. The symposium will be held at Pepperdine ...
(Date:2/23/2017)... ... 2017 , ... ERT, a global data and technology company ... a leading clinical development service provider, has selected ERT’s Trial Oversight suite as ... part to an array of circumstances including the use of multiple data capture ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center for Autism ... Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly ... (ASD) to see films in an environment that accommodates their unique needs. , ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24 février 2017 ITL Limited, ( ASX : ITD ), ... ravie d,annoncer les excellents résultats semestriels clos le 31 ... Une présentation complète « Résultats et mise à jour sur ... . Faits marquants ... 1,04 million $ ; en hausse de 104 %) ...
(Date:2/24/2017)... 24, 2017 Medivir AB (Nasdaq ... a new Board of Directors that will be submitted ... Committee comprises representatives of the company,s three largest shareholders ... who have accepted a seat on the Nomination Committee, ... the 2016-2017 Nomination Committee was as follows:  ...
(Date:2/23/2017)...  Genesis Healthcare Services has merged with Hospice Cloud, ... Bill Monast , President and CEO of Hospice ... Feltman , executives with Home Health Depot, Inc., the ... This acquisition helps Hospice Cloud maintain its position ... medical equipment (DME) solutions for the hospice industry. ...
Breaking Medicine Technology: